Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
fda
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acetylon pharmaceuticals
alder biopharmaceutical
allergan
ambys medicines
american academy of neurology
amgen
antibiotics
arvinas
What
make
3
×
big
new
aiming
ambys
approval
arguments
biotech
biotechs
chose
class
close
commercialized
companies
company
competitors
control
deadly
deal
debuted
decades
device
diseases
drug
drugs
fda
firms
formed
future
ipo
ipos
launch
life
liver
medical
medicines
meeting
migraine
neuro
open
Language
Current search:
make
×
" national top stories "
×
biotech
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?